Immunofluorescence Assay Market Scenario
Rise prevalence of chronic diseases, technological advancements in the field of Immunofluorescence Assay and rising R&D and healthcare spending are some of the major factors propelling the Immunofluorescence Assay market globally. Furthermore, increasing government funding for life science research is also one of the factor propelling the growth of Immunofluorescence Assay market. However, high instrument costs is one of the major factor expected to hamper the global growth of the market.
Immunofluorescence Assay Market Segmentation
The Immunofluorescence Assay market is segmented by Product, Type, Disease, End User and Geography. The Products studied in the report are Reagents (Stains & Dyes, Media & Sera, Fixatives, Buffers, Probes, Solvents and Other Reagents), Instruments (Microscopes and Imaging Analysis Systems), Antibodies (Primary Antibodies and Secondary Antibodies), Kits and Consumables & Accessories. Furthermore, the Type comprises of Indirect Immunofluorescence and Direct Immunofluorescence. In addition, the Disease includes Cancer, Infectious Diseases, Cardiovascular Diseases, Autoimmune Diseases and Other Diseases. In addition, immunofluorescence assay products are used in various End Users such as Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Contract Research Organizations. Based on Geography, the Immunofluorescence Assay Market is studied across the countries of key regions such as, North America, Europe, Asia Pacific and RoW.
Immunofluorescence Assay Market by Geography
Based on geography, the Immunofluorescence Assay market is studied across the countries of key regions such as, North America, Europe, Asia Pacific and RoW. Among all the regions, the North America is anticipated to hold the major share of the global Immunofluorescence Assay market. Major drivers include rising healthcare spending in the U.S. and support from government organizations in the country. Moreover, rising prevalence of chronic diseases in this region is also expected to support the growth of the market.
Immunofluorescence Assay Market Key Players
Some of the major players operating in the global Immunofluorescence Assay market includes Thermo Fisher Scientific, Inc., Abcam Plc, Bio-Rad Laboratories, Inc., Perkinelmer, Inc., Merck Kgaa, Werfen Company, Cell Signaling Technology, Inc., Medipan Gmbh, Sino Biological, Inc., Danaher Corporation, Maravai Lifesciences, Enzo Biochem, Inc., Becton, Dickinson And Company (Bd), Olympus Corporation, Nikon Corporation, Bruker Corporation and Agilent Technologies.
Immunofluorescence Assay Market Report Key Benefits